Cite
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study.
MLA
Bellantone, Rocco, et al. “Validity of Thyroglobulin MRNA Assay in Peripheral Blood of Postoperative Thyroid Carcinoma Patients in Predicting Tumor Recurrences Varies According to the Histologic Type: Results of a Prospective Study.” Cancer (0008543X), vol. 92, no. 9, Nov. 2001, pp. 2273–79. EBSCOhost, https://doi.org/10.1002/1097-0142(20011101)92:9<2273::AID-CNCR1573>3.0.CO;2-Y.
APA
Bellantone, R., Lombardi, C. P., Bossola, M., Ferrante, A., Princi, P., Boscherini, M., Maussier, L., Salvatori, M., Rufini, V., Reale, F., Romano, L., Tallini, G., Zelano, G., Pontecorvi, A., Bellantone, R., Lombardi, C. P., Bossola, M., Ferrante, A., Princi, P., & Boscherini, M. (2001). Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. Cancer (0008543X), 92(9), 2273–2279. https://doi.org/10.1002/1097-0142(20011101)92:9<2273::AID-CNCR1573>3.0.CO;2-Y
Chicago
Bellantone, Rocco, Celestino Pio Lombardi, Maurizio Bossola, Angela Ferrante, Pietro Princi, Mauro Boscherini, Ludovica Maussier, et al. 2001. “Validity of Thyroglobulin MRNA Assay in Peripheral Blood of Postoperative Thyroid Carcinoma Patients in Predicting Tumor Recurrences Varies According to the Histologic Type: Results of a Prospective Study.” Cancer (0008543X) 92 (9): 2273–79. doi:10.1002/1097-0142(20011101)92:9<2273::AID-CNCR1573>3.0.CO;2-Y.